Bruno Sarmento, RESTORE’s researcher and leader of the Research Group “Nanomedicines & Translational Drug Delivery” of the Institute for Health Research and Innovation of the University of Porto (i3S), was recently elected Director-at-Large of the largest international scientific society in the field of controlled drug liberation systems, the Controlled Release Society (CRS). It thus becomes the first Portuguese to integrate the direction of this scientific organization.
After having held various functions within the Society, where he was also the president of the Focus Group of Nanomedicine and Nanoscale Drug Delivery, vice-president of the Iberian Chapter and co-founder of the Brazilian Chapter, having also been appointed a member of the Society’s College of Fellows, Bruno Sarmento considers that his candidacy and election “was a natural evolution”, taking into account his knowledge and experience on the area and “the degree of interaction with the most active members of CRS”.
For Bruno Sarmento, holding the position of Director-at-Large for this world scientific society represents “a challenge” and also “a unique opportunity to get to know even better the global reality of academic and industrial research of medicines, thanks to the proximity, which there will be, of scientific, technical and regulatory discussion with the people of greaterinternational reputation». The researcher also hopes “to be able to contribute to the strengthening of CRS as the world society that best promotes research in controlled drug release”. “This election is also a recognition of the work done by the research group, and by all former and current members, as well as to the institutions that have provided us with the necessary conditions, and to which I am grateful and acknowledged”.
